ArticleInternational journal of nephrology2025
Genetic Determinants of Chronic Kidney Disease (CKD) in India: A Comprehensive Genomewide Association Study (GWAS) Analysis.
Article in International journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic kidney disease (CKD) poses a major health burden globally and affects nearly 17% of the Indian population. Despite established risk factors such as diabetes and hypertension, significant interindividual variability suggests a genetic contribution to CKD susceptibility. This study explores genetic variants predisposing to CKD in the Indian population using a genomewide association approach. Methods: A total of 90 patients with CKD and 90 healthy controls were genotyped using the Illumina Infinium Global Screening Array (640,000 markers). After stringent quality control, 5.7 million genetic markers were retained for analysis. Single-nucleotide polymorphisms (SNPs) were assessed using logistic regression including age, sex, and ten principal components as covariates. Variants meeting standard genomewide significance thresholds ( Results: The study identified 87 SNP loci associated with CKD, of which two genes, MPP7 and MAD1L1, reached genomewide significance. Variants with extremely high odds ratios (e.g., MAD1L1 OR > 1000) were interpreted as possible methodological artifacts. SNPs in PDZK1IP1, ANO3, C3AR1, FTO, and CD70 demonstrated suggestive biomarker potential (OR < 10, Conclusion: This genomewide analysis represents one of the first studies on CKD genetics in the Indian population. While the MPP7 variant emerges as a credible susceptibility locus, several other SNPs show promising biomarker potential. Larger, multiethnic studies and functional validation are needed to confirm their roles in CKD pathogenesis and therapeutic targeting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.